Medical Condition News

RSS

First study in North America uses genetic testing to identify people at risk of heart disease

Dignity Health in Arizona is launching the first research study in North America in which genetic testing is used to identify men and women at risk of developing heart disease based on the makeup of their DNA.

21 Feb 2022

High-fiber diet linked with reduced risk of developing dementia

We're always hearing that we should eat more fiber. It's known to be vitally important for a healthy digestive system and also has cardiovascular benefits like reduced cholesterol.

21 Feb 2022

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, similar to the non-communicable diseases cancer, obesity, cardiovascular disease and diabetes.

18 Feb 2022

T-cell responses linked with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer

T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer, with lower T-cell responses observed in patients with blood cancers.

18 Feb 2022

Music therapy is beneficial for patients with sickle cell disease

A new study from University Hospitals (UH) Connor Whole Health found patients with Sickle Cell Disease (SCD) who participated in music therapy learned new self-management skills and improved their ability to cope with pain.

18 Feb 2022

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the online publication of a new manuscript, Exosome mediated genetic reprogramming of tumor associated macrophages by exoASO-STAT6 leads to potent monotherapy anti-tumor efficacy, in the American Association for the Advancement of Science's journal, Science Advances.

18 Feb 2022

New class of molecules can correct cerebrovascular defects in brain pathologies

An impressive number of brain pathologies are closely linked to major cerebrovascular defects, which are currently impossible to treat due to a lack of drugs.

18 Feb 2022

Study characterizes COVID-19 vaccine effectiveness at longer dose intervals

Researchers conducted a prospective cohort study to assess the level and durability of protection offered by two doses of COVID-19 vaccine against SARS-CoV-2 infection in participants with no history of a previous infection.

18 Feb 2022

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

In a new study, researchers evaluated the efficacy and safety of nirmatrelvir in mild to moderate COVID-19 patients who were at high risk of severe COVID-19 disease.

18 Feb 2022

Study offers insights into costs of treating dementia among American Indians and Alaska native adults

American Indian and Alaska Native (AI/AN) adults are at high risk for Alzheimer’s disease and related dementias (ADRD), yet little is known about resources allocated for their treatment.

18 Feb 2022

VA researchers shine light on the dangerous mental health consequences of COVID-19

The most menacing fallout from COVID-19 often shows itself only after the initial "acute" infection passes. A team of VA researchers has been shining a light on various dangerous and enduring consequences that can arise following the initial COVID bout. These COVID complications include mental health disorders.

18 Feb 2022

Drugs that increase fetal hemoglobin levels may help people with sickle cell disease

Sickle cell anemia is an inherited blood disorder where red blood cells become sickle/crescent shaped. It causes frequent infections, swelling in the hands and legs, pain, severe tiredness and delayed growth or puberty.

18 Feb 2022

Demonstrating effectiveness of BNT162b2 vaccine in preventing reinfections after COVID-19 recovery

Researchers conducted a retrospective cohort study to assess the rate of SARS-CoV-2 reinfection in patients who had recovered from COVID-19.

18 Feb 2022

Changes in the brain cortex of COVID-19 patients associated with inflammatory biomarkers

Recently, a team of researchers examined the neurotoxic damage to the brain’s cortical region in patients hospitalized due to COVID-19.

18 Feb 2022

mRNA vaccine-induced antibodies shown to be more effective in neutralizing SARS-CoV-2 and its variants than natural immunity

Researchers designed an electrochemiluminescence-based serology test with remarkable sensitivity to precisely quantify the amounts of anti-RBD antibodies in individuals infected with SARS-CoV-2.

18 Feb 2022

Role of quantitative, multiplexed, targeted proteomics in determining variant-specific SARS-CoV-2 antibody response

Researchers developed a ‘bait and capture’ system which was further followed by a multiplexed and targeted proteomic liquid chromatography-tandem mass spectrometry analyses for the comparison of immune correlates in response to vaccination, natural infection, as well as protection against SARS-CoV-2 variants.

18 Feb 2022

Novel blood biomarkers can potentially predict melanoma patients' response to immunotherapy

Melanoma, a type of skin cancer, is often curable when detected and treated in its early stages. However, the disease can rapidly spread to other organs in the body and become deadly. According to the American Cancer Society, more than 7,600 people die of the disease each year in the United States.

17 Feb 2022

Only half of the people with cardiovascular disease risk receive lifestyle support from GPs, study shows

A new 10-year analysis of people in England newly diagnosed with high blood pressure, high cholesterol or obesity shows only half receive lifestyle support from their GPs.

17 Feb 2022

Advanced imaging reveals the loss of brain synapses in patients with mild symptoms of Alzheimer's

Advanced imaging technology developed by Yale researchers has helped them confirm that the destruction of brain synapses underlies the cognitive deficits experienced by patients with Alzheimer's disease, according to a study published Feb. 17 in the journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

17 Feb 2022

Intermediate size nanoparticles may be effective at stopping internal bleeding

Traumatic injuries are the leading cause of death in the U.S. among people 45 and under, and such injuries account for more than 3 million deaths per year worldwide.

17 Feb 2022

Medical Condition News

First study in North America uses genetic testing to identify people at risk of heart disease

High-fiber diet linked with reduced risk of developing dementia

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

T-cell responses linked with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer

Music therapy is beneficial for patients with sickle cell disease

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

New class of molecules can correct cerebrovascular defects in brain pathologies

Study characterizes COVID-19 vaccine effectiveness at longer dose intervals

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

Study offers insights into costs of treating dementia among American Indians and Alaska native adults

VA researchers shine light on the dangerous mental health consequences of COVID-19

Drugs that increase fetal hemoglobin levels may help people with sickle cell disease

Demonstrating effectiveness of BNT162b2 vaccine in preventing reinfections after COVID-19 recovery

Changes in the brain cortex of COVID-19 patients associated with inflammatory biomarkers

mRNA vaccine-induced antibodies shown to be more effective in neutralizing SARS-CoV-2 and its variants than natural immunity

Role of quantitative, multiplexed, targeted proteomics in determining variant-specific SARS-CoV-2 antibody response

Novel blood biomarkers can potentially predict melanoma patients' response to immunotherapy

Only half of the people with cardiovascular disease risk receive lifestyle support from GPs, study shows

Advanced imaging reveals the loss of brain synapses in patients with mild symptoms of Alzheimer's

Intermediate size nanoparticles may be effective at stopping internal bleeding

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News